A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Semprex D Indications, Dosage, Storage, Stability - Acrivastine and Pseudoephedrine
Semprex D Indications, Dosage, Storage, Stability - Acrivastine and Pseudoephedrine
INDICATIONS
SEMPREX-D Capsules are indicated for relief
of symptoms associated with seasonal allergic
rhinitis such as sneezing,
rhinorrhea, pruritus, lacrimation, and nasal
congestion. SEMPREX-D Capsules should be administëred when both the
antihistaminic activity
of acrivastine and the nasal
decongestant activity of pseudoephedrine are desired (see CLINICAL
PHARMACOLOGY). The efficacy of SEMPREX-D Capsules beyond 14 days
of continuous treatment
in patients with seasonal allergic
rhinitis has not been adequately
investigated in clinical
trials.
SEMPREX-D Capsules have not been adequately studied for effectiveness
in relieving the symptoms of the common cold.
DOSAGE AND ADMINISTRATION
The recommended dosage for
adults and children 12 years and older is one capsule
administered orally, every 4 to 6 hours four times a day.
HOW SUPPLIED
SEMPREX-D Capsules (dark green opaque cap and white opaque
body with a yellow band) contain acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg. The cap
is printed with "404" in white ink, and the body and the body is printed with “SEMPREX-D” in black
ink.
- NDC 53014-404-10 Bottle of 100's
Store at 15° to 25° C (59° to 77°
F) in a dry place and protected from light. Keep out of the reach of children.
top
